STAT

Evidence from the field: Fractional doses of yellow fever vaccine provided protection, study finds

Health workers resorted to using fractional doses of yellow fever vaccine in the midst of an outbreak. The fractional doses seem to have worked.
A health worker in Kinshasa carries a supply of yellow fever vaccine.

A 2016 emergency yellow fever vaccination campaign that had to resort to using smaller than standard doses because of a global vaccine shortage appears to have protected the people who were vaccinated, a new study suggests.

People who received a fractional dose — one-fifth the standard size — showed strong immune responses a month after they received the single dose of vaccine, the authors reported in the New England Journal of Medicine.

While the study — conducted during a mass vaccination campaign in Kinshasa, capital of the Democratic Republic of Congo —

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks